
Gaxos Divests Gaming Assets; Q1 Revenue Jumps to $1.81M
Gaxos.ai Inc. has completed the divestment of its gaming assets, including Gaxos Gaming Labs, to Game Foundry AI, receiving 2.2 million shares valued at approximately $1.76 million. This strategic realignment focuses the company's resources on its commercially proven consumer and enterprise AI applications from Gaxos Labs and personalized health products from RNK Health. The company reported a significant revenue increase in Q1 2026 to $1.81 million, up from $24,000 in Q1 2025, driven by $1.25 million from RNK Health and $563,000 from Gaxos Labs subscriptions. CEO Vadim Mats emphasized focused execution, growing recurring revenue, improving customer acquisition efficiency, and disciplined capital allocation.
Key Highlights
- Completed sale of gaming assets to Game Foundry AI.
- Received 2.2 million shares of Game Foundry AI, valued at $1.76 million.
- Q1 2026 revenue increased to $1.81 million from $24,000 in Q1 2025.
- RNK Health contributed $1.25 million to Q1 2026 revenue.
- Gaxos Labs subscriptions contributed $563,000 to Q1 2026 revenue.
- Strategic focus on consumer/enterprise AI applications and health products.
- Maintains 19.99% ownership in America First Defense.AI.
Price Impact
More from GXAI